review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Pramod D Dhonde | |
Satish V Khadilkar | |||
Shrikant S Deshmukh | |||
P2860 | cites work | Vasculitic neuropathy : clinical electrophysiological and histopathological characterstics | Q95477888 |
Length dependence of variables associated with temporal dispersion in human motor nerves | Q30320992 | ||
Distal acquired demyelinating symmetric neuropathy | Q33841623 | ||
Neuromuscular complications of connective tissue diseases | Q34141653 | ||
POEMS syndrome: definitions and long-term outcome | Q34161383 | ||
Chronic inflammatory demyelinating polyneuropathy accompanied by hepatocellular carcinoma. | Q34738368 | ||
Transcutaneous cervical root stimulation in the diagnosis of multifocal motor neuropathy with conduction block | Q35476778 | ||
Advances in understanding and treatment of immune-mediated disorders of the peripheral nervous system | Q35842193 | ||
Multifocal motor neuropathy: current concepts and controversies. | Q36072147 | ||
Monoclonal gammopathy of undetermined significance, Waldenström macroglobulinemia, AL amyloidosis, and related plasma cell disorders: diagnosis and treatment | Q36480921 | ||
Anti-myelin-associated glycoprotein neuropathy | Q36592059 | ||
Paraproteinemic neuropathy | Q36745949 | ||
What's new in multifocal motor neuropathy in 2007-2008? | Q37385090 | ||
Anti-GM2 IgM antibodies: clinical correlates and reactivity with a human neuroblastoma cell line. | Q40946779 | ||
The systemic amyloidoses | Q41596634 | ||
Diagnostic approach to central and peripheral nervous system vasculitis | Q41641708 | ||
Polyarteritis nodosa, microscopic polyangiitis, and Churg-Strauss syndrome: clinical aspects, neurologic manifestations, and treatment | Q41641735 | ||
Clinical and neurophysiological assessment of immunoglobulin therapy in five patients with multifocal motor neuropathy | Q41663344 | ||
Multifocal motor neuropathy without overt conduction block | Q41702502 | ||
The sensitivity and specificity of anti-GM1 antibody testing | Q42553258 | ||
Cladribine in the treatment of IgM paraproteinemic polyneuropathy | Q44187817 | ||
Chronic inflammatory demyelinating polyradiculoneuropathy. Clinical characteristics, course, and recommendations for diagnostic criteria | Q46619488 | ||
IVIg dose increase in multifocal motor neuropathy: a prospective six month follow-up | Q48006982 | ||
Mycophenolate mofetil as adjunctive therapy for MMN patients: a randomized, controlled trial | Q48107965 | ||
Distinctive abnormalities of motor axonal strength-duration properties in multifocal motor neuropathy and in motor neurone disease | Q48463928 | ||
The long-term effect of intravenous immunoglobulin treatment in multifocal motor neuropathy | Q48486772 | ||
Multifocal motor neuropathy: long-term clinical and electrophysiological assessment of intravenous immunoglobulin maintenance treatment | Q48536321 | ||
Activity-dependent conduction block in multifocal motor neuropathy: magnetic fatigue test | Q48679319 | ||
How long is IVIg effective in multifocal motor neuropathy? | Q51021985 | ||
Placebo-controlled trial of rituximab in IgM anti-myelin-associated glycoprotein antibody demyelinating neuropathy. | Q51743176 | ||
What is the best diagnostic index of conduction block and temporal dispersion? | Q53689960 | ||
Multifocal motor neuropathy improved by IVIg: randomized, double-blind, placebo-controlled study. | Q53901414 | ||
Intermittent cyclophosphamide and prednisone treatment of polyneuropathy associated with monoclonal gammopathy of undetermined significance. | Q53980487 | ||
A long-term study of prognosis in monoclonal gammopathy of undetermined significance. | Q55035699 | ||
Neuronal antinuclear antibody in sensory neuronopathy from lung cancer. | Q55060391 | ||
Motor Neuropathy with Proximal Multifocal Persistent Conduction Block, Fasciculations and Myokymia | Q56608957 | ||
Multifocal motor neuropathy: Is conduction block essential? | Q56929758 | ||
Multifocal motor neuropathy with and without conduction block: A single entity? | Q59243994 | ||
Neuropathy with onion bulb formations and pure motor manifestations | Q62803885 | ||
Multifocal demyelinating motor neuropathy: cranial nerve involvement and immunoglobulin therapy | Q68075974 | ||
Visual evoked potentials in patients with neuropathy and macroglobulinemia | Q69015007 | ||
Monoclonal IgM with unique specificity to gangliosides GM1 and GD1b and to lacto-N-tetraose associated with human motor neuron disease | Q69025264 | ||
Slow resolution of multifocal weakness and fasciculation: a reversible motor neuron syndrome | Q69599049 | ||
A treatable multifocal motor neuropathy with antibodies to GM1 ganglioside | Q69836574 | ||
Gangliosides GM1 and GD1b are antigens for IgM M-protein in a patient with motor neuron disease | Q70035461 | ||
[Anti-Gm1 antibodies in motor system diseases and neuropathies] | Q70251345 | ||
Nomenclature of amyloid and amyloidosis. WHO-IUIS Nomenclature Sub-Committee | Q70577268 | ||
Conduction block and denervation in Guillain-Barré polyneuropathy | Q71270566 | ||
Vasculitic neuropathy: profile of twenty patients | Q71272963 | ||
Persistent and transient "conduction block" in motor neuron diseases | Q72890170 | ||
Multifocal motor neuropathy presenting as ophthalmoplegia | Q73115212 | ||
Pulsed high-dose dexamethasone is not effective in patients with multifocal motor neuropathy | Q73245639 | ||
Multifocal motor neuropathy: diagnostic criteria that predict the response to immunoglobulin treatment | Q73298577 | ||
Magnetic resonance imaging of the brachial plexus in patients with multifocal motor neuropathy | Q73343604 | ||
Natural history of 46 patients with multifocal motor neuropathy with conduction block | Q73864084 | ||
Multifocal motor neuropathy. Serum IgM anti-GM1 ganglioside antibodies in most patients detected using covalent linkage of GM1 to ELISA plates | Q73884492 | ||
Motor and sensory demyelinating mononeuropathy multiplex (multifocal motor and sensory demyelinating neuropathy): a separate entity or a variant of chronic inflammatory demyelinating polyneuropathy? | Q74279484 | ||
Deterioration of multifocal motor neuropathy after plasma exchange | Q74575154 | ||
Chronic neuropathy with IgM anti-ganglioside antibodies: lack of long term response to rituximab | Q75205847 | ||
Multifocal motor neuropathy: pathologic alterations at the site of conduction block | Q76387429 | ||
Antiganglioside antibodies in polyneuropathy associated with monoclonal gammopathy | Q77292658 | ||
Are multifocal motor neuropathy and Lewis-Sumner syndrome distinct nosologic entities? | Q77758992 | ||
Multifocal acquired demyelinating sensory and motor neuropathy: the Lewis-Sumner syndrome | Q77758996 | ||
Upper limb predominant, multifocal chronic inflammatory demyelinating polyneuropathy | Q77873391 | ||
Antiganglioside antibodies in multifocal acquired sensory and motor neuropathy | Q78810728 | ||
Triple-stimulation technique in multifocal neuropathy with conduction block | Q79661913 | ||
Guidelines in electrodiagnostic medicine. Consensus criteria for the diagnosis of partial conduction block | Q80144059 | ||
Follow-up study and response to treatment in 23 patients with Lewis-Sumner syndrome | Q80407989 | ||
Chronic immune sensory polyradiculopathy: a possibly treatable sensory ataxia | Q80980704 | ||
Multifocal motor neuropathy | Q81197431 | ||
Multifocal motor neuropathy | Q81679400 | ||
P433 | issue | 2 | |
P921 | main subject | polyradiculoneuropathy | Q3395796 |
P304 | page(s) | 81-92 | |
P577 | publication date | 2011-04-01 | |
P1433 | published in | Annals of Indian Academy of Neurology | Q4767851 |
P1476 | title | Chronic dysimmune neuropathies: Beyond chronic demyelinating polyradiculoneuropathy | |
P478 | volume | 14 |
Q38312251 | A practical approach to enlargement of nerves, plexuses and roots |
Q90151428 | Early Aggressive Immunotherapy Improves Functional Outcome in Chronic Immune Sensory Polyradiculopathy |
Q34316260 | Pure Motor Axonal Neuropathy, Organomegaly, Impaired Glucose Tolerance, M Protein, Skin Changes, Multiple Plasmacytomas & Acute Interstitial Nephritis in Osteolytic Myeloma: Beyond POEMS! |
Q38698738 | Utility of somatosensory evoked potentials in the assessment of response to IVIG in a long-lasting case of chronic immune sensory polyradiculopathy |
Search more.